XBIT Stock Chart

XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development, and commercialization of therapeutic antibodies based on its True Human™ proprietary technology.

XBiotech’s True Human™ antibodies are 100 percent human, derived from individuals who possess a natural immunity to certain diseases. With the discovery and clinical programs across multiple disease areas, XBiotech’s True Human™ antibodies have the potential to harness the body’s natural immunity to fight the disease with increased safety, efficacy and tolerability.

XBiotech is currently advancing a robust pipeline of antibody therapies to exceed the standards of care in oncology, inflammatory conditions and infectious diseases.